RCMU
ONC icon

Rokos Capital Management (UK)’s BeOne Medicines Ltd ONC Stock Holding History

Rokos Capital Management (UK)’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-14,335
Closed -$4.26M – 267
2026
Q1 		$4.26M Buy
+14,335
New +$4.64M 0.03% 147

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Rokos Capital Management (UK)'s ONC Position: Q2 2026 in Review

Rokos Capital Management (UK) sold out of BeOne Medicines Ltd (ONC) in Q2 2026, closing a stake of 14,335 shares — an estimated $4.26M sold.

Rokos Capital Management (UK) first reported a position in ONC in Q1 2026 and held it in 1 quarter. The position peaked at $4.26M in Q1 2026. 283 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Rokos Capital Management (UK) reported no remaining BeOne Medicines Ltd position as of Q2 2026 after selling out during the quarter.
  • Rokos Capital Management (UK) sold 14,335 BeOne Medicines Ltd shares in Q2 2026, an estimated $4.26M.
  • Rokos Capital Management (UK) first reported a position in BeOne Medicines Ltd in Q1 2026 and held it in 1 quarter.
  • Rokos Capital Management (UK)'s BeOne Medicines Ltd position peaked at $4.26M in Q1 2026.
  • 283 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Rokos Capital Management (UK)'s 13F filing for Q2 2026, filed 14 Aug 2026.